Apollo completes CAR-T therapy in five patients
Apollo Cancer Centres in Visakhapatnam has successfully performed CAR-T therapy on five patients with relapsed blood cancers. This milestone marks a significant advancement in oncology treatment within the region.
Why it matters
CAR-T therapy is a cutting-edge medical treatment, and its successful implementation in regional centers improves accessibility to advanced cancer care.
Apollo Cancer Centres in Visakhapatnam has achieved a milestone in oncology by successfully completing Chimeric Antigen Receptor T-cell (CAR-T) therapy in five patients with relapsed and refractory blood cancers.
The article is a straightforward report on a medical achievement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in